Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Excelsior Medical CoTPE:4104 -0.28%87 ROA % is 4.27% as of Mar. 2026, which is 5% above its 10-year median of 4.06. GuruFocus rates TPE:4104 with a GF Score™ of 87/100 and a GF Value™ of NT$87.68 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 119 Medical Distribution companies, Excelsior Medical Co ranks better than 73.95% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Excelsior Medical Co's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$821 Mil.
Excelsior Medical Co's average Total Assets over the quarter that ended in Mar. 2026 was NT$19,221 Mil. Therefore, Excelsior Medical Co's annualized ROA % for the quarter that ended in Mar. 2026 was 4.27%.
The historical rank and industry rank for Excelsior Medical Co's ROA % or its related term are showing as below:
TPE:4104'
s ROA % Range Over the Past 10 Years
Min: 2.4 Med: 4.06 Max: 4.32
Current: 4.32
During the past 13 years, Excelsior Medical Co's highest ROA % was 4.32%. The lowest was 2.40%. And the median was 4.06%.
TPE:4104's ROA % is ranked better than 73.95% of 119
companies
in the Medical Distribution industry
Industry Median: 2.23
vs TPE:4104: 4.32
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Excelsior Medical Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Excelsior Medical Co ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's ROA % distribution charts can be found below:
* The bar in red indicates where Excelsior Medical Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Excelsior Medical Co (TPE:4104) has a ROA % of 4.27% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Excelsior Medical Co and its competitors. This is near median its historical median of 4.06. Over the past decade, Excelsior Medical Co's ROA % has ranged from 2.40 to 4.32. According to the industry distribution chart, Excelsior Medical Co ranks #31 out of 119 companies in the Medical Distribution industry, placing it in the top 26.1%.
Is Excelsior Medical Co's ROA % too high?
Excelsior Medical Co's current ROA % of 4.27% is near median its 10-year median of 4.06. Over the past 10 years, this metric has ranged from a low of 2.40 to a high of 4.32. The Medical Distribution industry median ROA % is 2.23. Excelsior Medical Co's value of 4.27% is 91.5% above this industry median. Based on the distribution chart, Excelsior Medical Co ranks #31 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's ROA % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Excelsior Medical Co ranks #31 out of 119 companies for ROA %. This puts Excelsior Medical Co in the upper half of its industry. The industry median ROA % is 2.23. Excelsior Medical Co's value of 4.27% is 91.5% above this benchmark. Historically, Excelsior Medical Co's own ROA % has ranged from 2.40 to 4.32 over the past decade. While the company's 10-year median is 4.06 vs. the industry median of 2.23, Excelsior Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.23, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Excelsior Medical Co's current ROA % of 4.27% is 91.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Excelsior Medical Co and its competitors. For the Medical Distribution industry, the median ROA % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Excelsior Medical Co's current ROA % is 4.27%, which is near median its own 10-year median of 4.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$70.80 — trading 19.3% below its estimated fair value. The current ROA % is 4.27%, which is near median its 10-year median of 4.06 and 91.5% above the Medical Distribution industry median of 2.23. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current ROA % is 4.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?
Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued.
The current stock price of NT$70.80 is trading 19.3% below its estimated GF Value™ of NT$87.68.
GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.
Key valuation signals for TPE:4104:
ROA %: 4.27% (near median its 10-year median of 4.06)
GF Value™: NT$87.68 vs. price of NT$70.80 (19.3% below fair value)
Industry Position: 91.5% above the Medical Distribution median (#31 of 119)
No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score
Get the complete analysis for TPE:4104
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4104 has been successfully added to your 
